Exercise of Options & PDMR Dealings
14th Nov 2025 08:38
14 November 2025
Avingtrans Plc
("Avingtrans", the "Company", or the "Group")
Exercise of Options & PDMR Dealings
Avingtrans plc (AIM: AVG), which designs, manufactures and supplies critical components, modules, systems and associated services to the energy, medical and industrial sectors, announces that on 13 November 2025, the Company was notified of the exercise of 591,614 options over ordinary shares of 5p each in the Company ("Ordinary Shares") by Steve McQuillan, Chief Executive Officer, and Stephen King, Chief Financial Officer, pursuant to the Company's Executive Shared Ownership Plans (the "ExSOP Options").
Details of the exercise of ExSOP Options by Steve McQuillan and Stephen King, together with subsequent beneficial holdings of each individual following the transactions, are set out below.
PDMR | Role | FY 2019 ExSOP options exercised | FY 2016 ExSOP options exercised | Beneficial interest in Ordinary Shares following the transactions | Resulting percentage holding of enlarged total voting rights held |
Steve McQuillan | Chief Executive Officer | 77,061 | 258,877 | 806,925 | 2.44% |
Stephen King | Chief Financial Officer | 68,254 | 187,422 | 667,614 | 2.02% |
The 591,614 Ordinary Shares are currently held by the Company's Employee Benefit Trust and will be transferred to Steve McQuillan and Stephen King and, as such, no new Ordinary Shares have been issued in connection with the transactions.
Therefore, the total number of Ordinary Shares with voting rights in the Company remains at 33,130,422. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Group under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.
Enquiries:
Avingtrans plc | 01354 692 391 |
Roger McDowell, Chairman Steve McQuillan, Chief Executive Officer Stephen King, Chief Financial Officer
|
|
Singer Capital Markets (Nominated Adviser and Broker) | 020 7496 3000 |
Sara Hale Alex Bond Oliver Platts |
|
IFC Advisory (Financial PR) |
020 3934 6630 |
Graham Herring Tim Metcalfe Zach Cohen |
|
About Avingtrans plc:
Avingtrans designs, manufactures and supplies original equipment, systems and associated aftermarket services to the energy, medical and industrial markets worldwide.
Business units
Hayward Tyler - Luton, East Kilbride UK, USA, China and India Specialises in the design, manufacture and servicing of performance-critical motors and pumps for challenging environments. Energy Steel, Inc - Rochester Hills, Michigan, USA Provider of custom fabrications for the nuclear industry, specialising in: OEM parts obsolescence; custom fabrications; engineering design solutions; product refurbishment; on-site technical support. Stainless Metalcraft Ltd - Chatteris, UK Provider of safety-critical equipment for the energy, medical, science and research communities, worldwide, specialising in precision pressure and vacuum vessels and associated fabrications, sub-assemblies and systems. Booth Industries - Bolton, UK Designs, manufactures, installs and services doors and walls which can be tailored to be: blast and explosion proof; fireproof; acoustically shielded; high security/safety; or combinations of the above. Ormandy Group - Bradford, UK Design, manufacturers and servicing of off-site plant, heat exchangers and other HVAC (heating, ventilation and air conditioning) products. Slack & Parr - Kegworth, UK, USA & China Design, manufacture and servicing of high-precision gear metering pumps, hydraulics flow dividers and industrial pumps. Composite Products Ltd - Buckingham, UK Centre for composite technology, parts and assemblies, serving customers in industrial markets. Adaptix Ltd - Oxford, UK Adaptix has developed novel 3D X-ray for Orthopaedic and Veterinary applications amongst others. Commercialisation of this system (and others) is on-going. Magnetica Ltd - Brisbane, Australia Magnetica Limited specialises in the development of next generation MRI technologies, including dedicated extremity MRI systems and MRI system components. Magnetica has successfully built and tested a compact, integrated 3 Tesla orthopaedic MRI system, demonstrating clinical-quality imaging. Commercialisation of this system (and others) is on-going. Magnetica's structure now includes two other business units: Scientific Magnetics - Abingdon, UK Designs and manufactures superconducting magnet systems and associated cryogenics for a variety of markets including MRI and provides services for Nuclear Magnetic Resonance instruments. Tecmag Inc - Houston, USA Designs, manufactures and installs instrumentation, including consoles, system upgrades, and probes, mainly for Magnetic Resonance Imaging (MRI) and Nuclear Magnetic Resonance (NMR) systems. | ||||||||||||||||
1 | Details of the person discharging managerial responsibilities / person closely associated
|
| ||||||||||||||
a)
| Name
| 1. Steve McQuillan 2. Stephen King |
| |||||||||||||
2
| Reason for the notification
|
| ||||||||||||||
a)
| Position/status
| 1. Chief Executive Officer 2. Chief Financial Officer |
| |||||||||||||
| Initial notification /Amendment
| Initial notification |
| |||||||||||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
| ||||||||||||||
a)
| Name
| Avingtrans PLC |
| |||||||||||||
b)
| LEI
| 213800ZZ96CKPI423E86
|
| |||||||||||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
| ||||||||||||||
a)
| Description of the financial instrument, type of instrument | Ordinary Shares of 5p each |
| |||||||||||||
| ||||||||||||||||
Identification code | ISIN: GB0009188797
|
| ||||||||||||||
| ||||||||||||||||
b)
| Nature of the transaction
| Exercise of options pursuant to the FY 2019 ExSOP
|
| |||||||||||||
c)
| Price(s) and volume(s) |
|
|
| ||||||||||||
d)
| Aggregated information | n/a |
| |||||||||||||
| ||||||||||||||||
- Aggregated volume |
| |||||||||||||||
| ||||||||||||||||
- Price |
| |||||||||||||||
| ||||||||||||||||
e)
| Date of the transaction
| 13 November 2025 |
| |||||||||||||
f)
| Place of the transaction
| Off market |
| |||||||||||||
1 | Details of the person discharging managerial responsibilities / person closely associated
| |||||||||||||
a)
| Name
| 1. Steve McQuillan 2. Stephen King | ||||||||||||
2
| Reason for the notification
| |||||||||||||
a)
| Position/status
| 1. Chief Executive Officer 2. Chief Financial Officer | ||||||||||||
| Initial notification /Amendment
| Initial notification | ||||||||||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||||||||||
a)
| Name
| Avingtrans PLC | ||||||||||||
b)
| LEI
| 213800ZZ96CKPI423E86
| ||||||||||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||||||||||
a)
| Description of the financial instrument, type of instrument | Ordinary Shares of 5p each | ||||||||||||
Identification code | ISIN: GB0009188797
| |||||||||||||
b)
| Nature of the transaction
| Exercise of options pursuant to the FY 2016 ExSOP
| ||||||||||||
c)
| Price(s) and volume(s) |
|
| |||||||||||
d)
| Aggregated information | n/a | ||||||||||||
- Aggregated volume | ||||||||||||||
- Price | ||||||||||||||
e)
| Date of the transaction
| 13 November 2025 | ||||||||||||
f)
| Place of the transaction
| Off market | ||||||||||||